Alzamend Neuro Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.07

+0.02 (+1.90%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,537.4% upside

Low Target $24.59

Average Target $38.92

High Target $51.00

Current Price $1.07

Current
$1.07

Target
$38.92

$24.59 $38.92 avg $51.00

Scenario Analysis

Bear Case

$24.59

2,198.1%

Low target

Base Case

$38.92

+3,537.4%

Avg target

Bull Case

$51.00

+4,666.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$9.90

-89.2% from high

52-Week Low

$1.46

+-26.7% from low

Target vs 52W High

$38.92

+293.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%